Adam Szpechcinski

4PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 14, 2026
Identification of Actionable Gene Variants in Pulmonary Large-Cell Neuroendocrine Carcinoma: A Real-World Analysis of a Polish Cohort.

Adam Szpechcinski, Magdalena Pelc, Urszula Lechowicz

|Jul 27, 2024
The Advantage of Targeted Next-Generation Sequencing over qPCR in Testing for Druggable EGFR Variants in Non-Small-Cell Lung Cancer.

Adam Szpechcinski, Joanna Moes-Sosnowska, Paulina Skronska

|Jul 27, 2022
Targeted Next-Generation Sequencing of Thymic Epithelial Tumours Revealed Pathogenic Variants in KIT, ERBB2, KRAS, and TP53 in 30% of Thymic Carcinomas.

Adam Szpechcinski, Malgorzata Szolkowska, Sebastian Winiarski

|Apr 07, 2019
The expression of circulating miR-504 in plasma is associated with EGFR mutation status in non-small-cell lung carcinoma patients.

Adam Szpechcinski, Mateusz Florczuk, Katarzyna Duk

Pageof 1

Frequent Collaborators

2 joint publications

Joanna Moes-Sosnowska

2 joint publications

Joanna Chorostowska-Wynimko

1 joint publications

Magdalena Knetki-Wroblewska

1 joint publications

Magdalena Pelc